Careers  |  Sign In  |  Register
Course List
  • CME Information

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education.

Support Statement

This activity is supported by an educational grant from Relypsa, Inc.


Hyperkalemia is associated with life-threatening cardiac arrhythmias and increased mortality. Patients at the highest risk are those with chronic kidney disease, with or without diabetes, or heart failure. Historically, patients with hyperkalemia had limited therapeutic options; however, recently, new agents have been developed to address this unmet need. This series of interviews focuses on the therapeutic advancements, particularly in patients with chronic kidney disease and heart failure. In addition, expert faculty will discuss various clinical scenarios and the use of novel potassium-lowering therapies for both acute and chronic hyperkalemia.

Target Audience

The intended audience for the activity is nephrologists, endocrinologists, cardiologists, internal medicine physicians, primary care physicians and other health care professionals involved in the treatment of patients with hyperkalemia.

Learning Objectives

Upon successful completion of the activity series, participants should be better able to:

  • Describe the pathophysiology of hyperkalemia, etiologic factors associated with its presentation, and its potential effect on multiple organ systems.
  • Review the symptoms that commonly present in patients with hyperkalemia to assist in determining the appropriate diagnostic follow-up.
  • Differentiate among the new and emerging agents for hyperkalemia for improved treatment selection.
  • Apply the efficacy and safety data of conventional therapy and emerging treatments when selecting therapy for hyperkalemia in patients with chronic kidney disease or end-stage renal disease and chronic heart failure.
  • Select the appropriate treatment for patients with diabetes and hyperkalemia.


George L. Bakris, MD, FASH, FAHA, FASN
Professor of Medicine
Director, ASH Comprehensive Hypertension Center
University of Chicago Medicine
Chicago, IL

Ileana L. Piña, MD, MPH
Professor, Department of Medicine
Professor, Department of Epidemiology & Population Health
Associate Chief, Academic Affairs
Montefiore Medical Center
Bronx, NY


Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP


Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™, 0.25 credits for each video. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACCME commendation logo

This enduring material is approved for 1 year from the date of original release, 12/14/2016 to 12/13/2017.

How To Participate in this Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, watch the videos, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the posttest questions correctly for each video. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.


In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

Faculty members report the following relationship(s):

George L. Bakris, MD, FASH, FAHA, FASN

Consulting Fees: AbbVie, Bayer, Janssen, Merck & Co, Relypsa

Contracted Research: Bayer

Ileana L. Piña, MD, MPH

No relevant financial relationships to disclose.

Reviewer reports the following relationship(s):

Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP

No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s):

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Educational Tools

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2016 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at